Lifecore Biomedical
(NASDAQ) LFCR
Lifecore Biomedical Financials at a Glance
Market Cap
$165.04M
Revenue (TTM)
$135.16M
Net Income (TTM)
$34.09M
EPS (TTM)
$-1.30
P/E Ratio
-3.37
Dividend
$0.00
Beta (Volatility)
1.22 (Average)
Dividend
$0.00
Beta (Volatility)
1.22 (Average)
Price
$4.46
Volume
195
Open
$4.51
Price
$4.46
Volume
195
Open
$4.51
Previous Close
$4.40
Daily Range
$4.34 - $4.68
52-Week Range
$3.63 - $8.98
Dividend
$0.00
Beta (Volatility)
1.22 (Average)
Price
$4.46
Volume
195
Open
$4.51
Previous Close
$4.40
Daily Range
$4.34 - $4.68
52-Week Range
$3.63 - $8.98
LFCR News
Why Landec Stock Crashed on Thursday
Are You Expecting This from Landec?
LFCR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lifecore Biomedical
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
382
CEO
Paul Josephs
Website
www.lifecore.comHeadquarters
Chaska, MN 55318, US
LFCR Financials
Key Financial Metrics (TTM)
Gross Margin
31%
Operating Margin
-0%
Net Income Margin
-25%
Return on Equity
-76%
Return on Capital
-0%
Return on Assets
-15%
Earnings Yield
-29.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$165.04M
Shares Outstanding
37.51M
Volume
195
Avg. Volume
323.41K
Financials (TTM)
Gross Profit
$40.30M
Operating Income
$17.25M
EBITDA
$8.81M
Operating Cash Flow
$206.00K
Capital Expenditure
$13.41M
Free Cash Flow
$13.62M
Cash & ST Invst.
$8.27M
Total Debt
$130.82M
Lifecore Biomedical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$23.19M
-34.0%
Gross Profit
$4.46M
-54.7%
Gross Margin
19.24%
N/A
Market Cap
$165.04M
N/A
Market Cap/Employee
$314.96K
N/A
Employees
524
N/A
Net Income
$14.98M
-1.4%
EBITDA
$2.36M
+67.3%
Quarterly Fundamentals
Net Cash
$129.35M
-3.5%
Accounts Receivable
$26.89M
+38.8%
Inventory
$28.16M
-18.6%
Long Term Debt
$148.80M
+18.6%
Short Term Debt
$1.34M
-72.7%
Return on Assets
-15.12%
N/A
Return on Invested Capital
-0.04%
N/A
Free Cash Flow
$3.58M
+184.2%
Operating Cash Flow
$4.70M
+291.7%